Question | Discussion | References | CME Credit

Case 2: Antiretroviral Regimens

You answered:

A Zidovudine-lamivudine (Combivir) plus efavirenz (Sustiva)

This answer is incorrect. Although the regimen zidovudine-lamivudine plus efavirenz was previously a preferred and widely used regimen, the zidovudine-lamivudine component is no longer recommended as a preferred nucleoside reverse transcriptase inhibitor combination. The NNRTI efavirenz is considered a preferred medication when used with tenofovir-emtricitabine (Truvada).

Choose another answer:

B Tenofovir-emtricitabine (Truvada) plus ritonavir (Norvir) plus darunavir (Prezista)
C Abacavir-lamivudine (Epzicom) plus raltegravir (Isentress)
D Tenofovir-emtricitabine (Truvada) plus lopinavir-ritonavir (Kaletra)

[Back to Case 2 Question | Go to Correct Answer]